GE HealthCare Discloses 2026 to 2028 Goals for Organic Revenue Growth

Dow Jones11-21 19:50

By Sabela Ojea

GE HealthCare said it expects further growth in the medium term, citing financial progress since its spin off from General Electric in 2023.

During its investor day, the Chicago maker of magnetic-resonance imaging scanners and other health-care machines guided for organic revenue growth of 4% to 6% from 2026 to 2028.

The company said it also forecasts growth in adjusted earnings, those which strip out one-time items, in the high-single digits to low-double digits.

Overall, GE HealthCare sees growth opportunities across the imaging, advanced visualization solutions, patient care solutions, and pharmaceutical diagnostics segments.

The company also backed its outlook for 2024 for organic revenue growth between 1% to 2%, trending toward the lower end of the range due to continued softness in the Chinese market.

On Oct. 31, GE Healthcare posted 25% growth in third-quarter profit and about a 1% increase in orders and revenue growth globally amid particular strength in the U.S. across all segments, according to Chief Executive Peter Arduini.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

November 21, 2024 06:50 ET (11:50 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485219464?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-21 19:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485219464","market":"fut","top_or_hot":-1,"title":"GE HealthCare Discloses 2026 to 2028 Goals for Organic Revenue Growth","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  GE HealthCare said it expects further growth in the medium term, citing financial progress since its spin off from General Electric in 2023. \n</p>\n<p>\n  During its investor day, the Chicago maker of magnetic-resonance imaging scanners and other health-care machines guided for organic revenue growth of 4% to 6% from 2026 to 2028. \n</p>\n<p>\n  The company said it also forecasts growth in adjusted earnings, those which strip out one-time items, in the high-single digits to low-double digits. \n</p>\n<p>\n  Overall, GE HealthCare sees growth opportunities across the imaging, advanced visualization solutions, patient care solutions, and pharmaceutical diagnostics segments. \n</p>\n<p>\n  The company also backed its outlook for 2024 for organic revenue growth between 1% to 2%, trending toward the lower end of the range due to continued softness in the Chinese market. \n</p>\n<p>\n  On Oct. 31, GE Healthcare posted 25% growth in third-quarter profit and about a 1% increase in orders and revenue growth globally amid particular strength in the U.S. across all segments, according to Chief Executive Peter Arduini. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 21, 2024 06:50 ET (11:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GE HealthCare Discloses 2026 to 2028 Goals for Organic Revenue Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGE HealthCare Discloses 2026 to 2028 Goals for Organic Revenue Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-21 19:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Sabela Ojea \n\n\n \n\n\n  GE HealthCare said it expects further growth in the medium term, citing financial progress since its spin off from General Electric in 2023. \n\n\n  During its investor day, the ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GE","symbol_name":"GE航空航天","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2485219464","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485219464","pubTimestamp":1732189800,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"GE HealthCare said it expects further growth in the medium term, citing financial progress since its spin off from General Electric in 2023.During its investor day, the Chicago maker of magnetic-resonance imaging scanners and other health-care machines guided for organic revenue growth of 4% to 6% from 2026 to 2028.The company said it also forecasts growth in adjusted earnings, those which strip out one-time items, in the high-single digits to low-double digits.Overall, GE HealthCare sees growth opportunities across the imaging, advanced visualization solutions, patient care solutions, and pharmaceutical diagnostics segments.The company also backed its outlook for 2024 for organic revenue growth between 1% to 2%, trending toward the lower end of the range due to continued softness in the Chinese market.On Oct. 31, GE Healthcare posted 25% growth in third-quarter profit and about a 1% increase in orders and revenue growth globally amid particular strength in the U.S. across all segments","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"GE":"GE航空航天","GEHC":"GE HEALTHCARE TECHNOLOGIES INC"},"translate_title":"GE医疗披露2026年至2028年有机收入增长目标","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GE":1,"GEHC":0.9},"content_text":"By Sabela Ojea \n\n\n \n\n\n  GE HealthCare said it expects further growth in the medium term, citing financial progress since its spin off from General Electric in 2023. \n\n\n  During its investor day, the Chicago maker of magnetic-resonance imaging scanners and other health-care machines guided for organic revenue growth of 4% to 6% from 2026 to 2028. \n\n\n  The company said it also forecasts growth in adjusted earnings, those which strip out one-time items, in the high-single digits to low-double digits. \n\n\n  Overall, GE HealthCare sees growth opportunities across the imaging, advanced visualization solutions, patient care solutions, and pharmaceutical diagnostics segments. \n\n\n  The company also backed its outlook for 2024 for organic revenue growth between 1% to 2%, trending toward the lower end of the range due to continued softness in the Chinese market. \n\n\n  On Oct. 31, GE Healthcare posted 25% growth in third-quarter profit and about a 1% increase in orders and revenue growth globally amid particular strength in the U.S. across all segments, according to Chief Executive Peter Arduini. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2024 06:50 ET (11:50 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Business Data","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485219464"}